Neurodegenerative Disease Research

Accelerate the development of effective therapies for Alzheimer’s and related neurodegenerative diseases.

We are committed to advancing drug development and pioneering scientific research to drive meaningful breakthroughs in neurodegenerative disease treatment.  

Strategic Focus:  Support early-stage therapeutic development and translational research in academia and biotech through a venture philanthropy model that catalyzes innovation and de-risks follow-on investment. 

Transforming Neurodegenerative Disease Research Through Collaboration

At the Foundation for a Better World, we unite philanthropic organizations, research institutions, and biotechnology companies to tackle the urgent challenges posed by neurodegenerative diseases, with a primary focus on Alzheimer's disease. Our mission is fueled by innovative partnerships and strategic investments that drive groundbreaking medical research. Key initiatives include:

Strategic Philanthropic Partnerships
We collaborate with leading drug discovery foundations to pool resources and expertise. These partnerships amplify the impact of our shared efforts, enabling us to support a wider array of research initiatives and fast-track the development of transformative therapies.

Venture Philanthropy Initiatives
By investing in early-stage biotechnology companies developing cutting-edge therapies for neurodegenerative diseases, we provide critical funding to advance promising innovations. These investments bridge the gap between discovery and delivery, bringing life-changing treatments closer to patients.

Support for Pioneering Researchers
We actively identify and fund groundbreaking research led by principal scientific investigators specializing in translational drug discovery. By supporting individual projects at their inception, we broaden the scope of early-stage development and foster breakthroughs that might otherwise go unexplored.

Through these collaborative efforts, we remain steadfast in our commitment to deepening the understanding of neurodegenerative diseases and delivering novel treatments that enhance the lives of patients.

Our Partners

 

Beneficiaries.